Peter Salzmann - Net Worth and Insider Trading
Peter Salzmann Net Worth
The estimated net worth of Peter Salzmann is at least $31 Million dollars as of 2024-05-11. Peter Salzmann is the CEO of Immunovant Inc and owns about 1,052,879 shares of Immunovant Inc (IMVT) stock worth over $31 Million. Details can be seen in Peter Salzmann's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter Salzmann has not made any transactions after 2024-04-17 and currently still holds the listed stock(s).
Transaction Summary of Peter Salzmann
Peter Salzmann Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter Salzmann owns 3 companies in total, including Corbus Pharmaceuticals Holdings Inc (CRBP) , Immunovant Inc (IMVTU) , and Immunovant Inc (IMVT) .
Click here to see the complete history of Peter Salzmann’s form 4 insider trades.
Insider Ownership Summary of Peter Salzmann
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings Inc | 2020-05-20 | director |
| IMVTU | Immunovant Inc | 2020-05-15 | director & Chief Executive Officer |
| IMVT | Immunovant Inc | 2024-04-17 | director & Chief Executive Officer |
Peter Salzmann Latest Holdings Summary
Peter Salzmann currently owns a total of 1 stock. Peter Salzmann owns 1,052,879 shares of Immunovant Inc (IMVT) as of April 17, 2024, with a value of $31 Million.
Latest Holdings of Peter Salzmann
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IMVT | Immunovant Inc | 2024-04-17 | 1,052,879 | 29.39 | 30,944,114 |
Holding Weightings of Peter Salzmann
Peter Salzmann Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter Salzmann has made a total of 21 transactions in Immunovant Inc (IMVT) over the past 5 years, including 0 buys and 21 sells. The most-recent trade in Immunovant Inc is the sale of 34,079 shares on April 17, 2024, which brought Peter Salzmann around $990,336.
Insider Trading History of Peter Salzmann
- 1
Peter Salzmann Trading Performance
Peter Salzmann Ownership Network
Peter Salzmann Owned Company Details
What does Corbus Pharmaceuticals Holdings Inc do?
Who are the key executives at Corbus Pharmaceuticals Holdings Inc?
Peter Salzmann is the director of Corbus Pharmaceuticals Holdings Inc. Other key executives at Corbus Pharmaceuticals Holdings Inc include Chief Financial Officer Sean F. Moran , director & Chief Executive Officer Yuval Cohen , and Chief Commercial Officer Craig Stuart Millian .
Corbus Pharmaceuticals Holdings Inc (CRBP) Insider Trades Summary
Over the past 18 months, Peter Salzmann made no insider transaction in Corbus Pharmaceuticals Holdings Inc (CRBP). Other recent insider transactions involving Corbus Pharmaceuticals Holdings Inc (CRBP) include a net purchase of 1,032,632 shares made by Cormorant Global Healthcare Master Fund, Lp , and a net purchase of 550,000 shares made by Cormorant Asset Management, Lp .
In summary, during the past 3 months, insiders sold 0 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) in total and bought 550,000 shares, with a net purchase of 550,000 shares. During the past 18 months, 0 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) were sold and 1,582,632 shares were bought by its insiders, resulting in a net purchase of 1,582,632 shares.
Corbus Pharmaceuticals Holdings Inc (CRBP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Corbus Pharmaceuticals Holdings Inc Insider Transactions
Peter Salzmann Mailing Address
Above is the net worth, insider trading, and ownership report for Peter Salzmann. You might contact Peter Salzmann via mailing address: 320 W 37th Street, 3rd Floor, New York Ny 10016.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
